The Chemours Company
Every calculator, already run for CC
Open the full toolkit →You have the numbers on CC. Get the argument.
A written report on which of these readings actually decide the outcome for The Chemours Company, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
9 analysts covering CCAnalyst Price Target Disagreement for The Chemours Company
Wall Street's bull case implies +70% from the current price; the bear case implies +6%. A 64% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for CC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexibl…
CC — frequently asked
Is CC a buy right now?
Wall Street's consensus rating on The Chemours Company is Buy across 9 analysts, with a mean price target of $18.78 (+33% vs. the current $14.13). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CC overvalued?
CC trades at — trailing earnings, against a DCF fair value of $69 per share. The current price implies -10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CC's next earnings date?
The Chemours Company is next scheduled to report earnings around Nov 5, 2026. A full CC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for The Chemours Company?
Analysts covering The Chemours Company (CC) range from a bear-case target of $15.00 to a bull-case high of $24.00, with a mean consensus target of $18.78 across 9 analysts. The spread of $9.00 (64% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare The Chemours Company against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For The Chemours Company
Start with the evergreen guides that matter most for Basic Materials, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on The Chemours Company, in minutes. 3 free reports included with every account — no credit card required.